‘GRANOLAS’ vs. the Magnificent Seven: Which should you dig into now?

These European and U.S. market darlings both come with spectacular trailing returns, overvaluation and investors’ FOMO.

Previous post This biotech ETF sees ‘breakout’ while U.S. small-cap technology stocks lag
Next post Look out, Super Micro: Dell is cementing itself as an AI play too